Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invivyd, Inc.

0.6136
-0.0166-2.63%
Volume:341.52K
Turnover:211.43K
Market Cap:73.61M
PE:-0.43
High:0.6491
Open:0.6490
Low:0.6086
Close:0.6302
Loading ...

BRIEF-Invivyd Inc Receives Deficiency Letter From Nasdaq

Reuters
·
28 Dec 2024

Invivyd Inc - Receives Deficiency Letter From Nasdaq

THOMSON REUTERS
·
28 Dec 2024

Invivyd Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
21 Nov 2024

Invivyd Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
20 Nov 2024

Q3 2024 Invivyd Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Nov 2024

Invivyd Inc (IVVD) Q3 2024 Earnings Call Highlights: Strong Revenue and Strategic Growth Amidst ...

GuruFocus.com
·
15 Nov 2024

Invivyd Inc reports results for the quarter - Earnings Summary

Reuters
·
15 Nov 2024

Invivyd, Inc. (IVVD) Reports Q3 Loss, Misses Revenue Estimates

Zacks
·
14 Nov 2024

Invivyd Q3 2024 GAAP EPS $(0.51) Misses $(0.34) Estimate, Total Revenue Was $9.3M

Benzinga
·
14 Nov 2024

Invivyd Q3 EPS USD -0.51

THOMSON REUTERS
·
14 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 Nov 2024

Invivyd announces manuscript preprint conveying data from CANOPY Phase 3 trial

TIPRANKS
·
12 Nov 2024

Invivyd Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Invivyd Inc - Canopy Trial Shows Strong Protection by Pemivibart in Immunocompetent Cohort

THOMSON REUTERS
·
12 Nov 2024

Invivyd Inc - Canopy Data Reconfirm High Risk Reduction in Immunocompetent Participants

THOMSON REUTERS
·
12 Nov 2024

Invivyd Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024

GlobeNewswire
·
06 Nov 2024